Association study of genetic variants of the ANGPTL3 gene and susceptibility to ischemic stroke

References

• Ekker MS, Boot EM, Singhal AB, et al. Epidemiology, aetiology, and management of ischaemic stroke in young adults. Lancet Neurol. 2018;17(9):790–801. doi:10.1016/S1474-4422(18)30233-330129475
   PubMed Web of Science ®Google Scholar
• Collaborators GBDCoD. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1736–1788. doi:10.1016/S0140-6736(18)32203-730496103
   PubMed Web of Science ®Google Scholar
• Wu S, Wu B, Liu M, et al. Stroke in China: advances and challenges in epidemiology, prevention, and management. Lancet Neurol. 2019;18(4):394–405. doi:10.1016/S1474-4422(18)30500-330878104
   PubMed Web of Science ®Google Scholar
• Pandian JD, Gall SL, Kate MP, et al. Prevention of stroke: a global perspective. Lancet. 2018;392(10154):1269–1278. doi:10.1016/S0140-6736(18)31269-830319114
   PubMed Web of Science ®Google Scholar
• Borne Y, Fagerberg B, Persson M, et al. Cadmium, carotid atherosclerosis, and incidence of ischemic stroke. J Am Heart Assoc. 2017;6:12. doi:10.1161/JAHA.117.006415
   Web of Science ®Google Scholar
• Sundstrom J, Soderholm M, Borne Y, et al. Eosinophil cationic protein, carotid plaque, and incidence of stroke. Stroke. 2017;48(10):2686–2692. doi:10.1161/STROKEAHA.117.01845028904229
   PubMed Web of Science ®Google Scholar
• Marulanda-Londono E, Chaturvedi S. Stroke due to large vessel atherosclerosis: five new things. Neurol Clin Pract. 2016;6(3):252–258. doi:10.1212/CPJ.000000000000024729443138
   PubMedGoogle Scholar
• Tikka A, Jauhiainen M. The role of ANGPTL3 in controlling lipoprotein metabolism. Endocrine. 2016;52(2):187–193. doi:10.1007/s12020-015-0838-926754661
   PubMed Web of Science ®Google Scholar
• Koishi R, Ando Y, Ono M, et al. Angptl3 regulates lipid metabolism in mice. Nat Genet. 2002;30(2):151–157. doi:10.1038/ng81411788823
   PubMed Web of Science ®Google Scholar
• Musunuru K, Pirruccello JP, Do R, et al. Exome sequencing, ANGPTL3 mutations, and familial combined hypolipidemia. N Engl J Med. 2010;363(23):2220–2227. doi:10.1056/NEJMoa100292620942659
   PubMed Web of Science ®Google Scholar
• Dewey FE, Gusarova V, Dunbar RL, et al. Genetic and Pharmacologic Inactivation of ANGPTL3 and cardiovascular disease. N Engl J Med. 2017;377(3):211–221. doi:10.1056/NEJMoa161279028538136
   PubMed Web of Science ®Google Scholar
• Conklin D, Gilbertson D, Taft DW, et al. Identification of a mammalian angiopoietin-related protein expressed specifically in liver. Genomics. 1999;62(3):477–482. doi:10.1006/geno.1999.604110644446
   PubMed Web of Science ®Google Scholar
• Shimizugawa T, Ono M, Shimamura M, et al. ANGPTL3 decreases very low density lipoprotein triglyceride clearance by inhibition of lipoprotein lipase. J Biol Chem. 2002;277(37):33742–33748. doi:10.1074/jbc.M20321520012097324
   PubMed Web of Science ®Google Scholar
• Camenisch G, Pisabarro MT, Sherman D, et al. ANGPTL3 stimulates endothelial cell adhesion and migration via integrin alpha vbeta 3 and induces blood vessel formation in vivo. J Biol Chem. 2002;277(19):17281–17290. doi:10.1074/jbc.M10976820011877390
   PubMed Web of Science ®Google Scholar
• Naoumova RP, Betteridge DJ. A new drug target for treatment of dyslipidaemia associated with type 2 diabetes and the metabolic syndrome? Lancet. 2002;359(9325):2215–2216.12103282
   PubMed Web of Science ®Google Scholar
• Hatsuda S, Shoji T, Shinohara K, et al. Association between plasma angiopoietin-like protein 3 and arterial wall thickness in healthy subjects. J Vasc Res. 2007;44(1):61–66. doi:10.1159/00009815317191020
   PubMed Web of Science ®Google Scholar
• Shoji T, Hatsuda S, Tsuchikura S, et al. Plasma angiopoietin-like protein 3 (ANGPTL3) concentration is associated with uremic dyslipidemia. Atherosclerosis. 2009;207(2):579–584. doi:10.1016/j.atherosclerosis.2009.05.02319540497
   PubMed Web of Science ®Google Scholar
• Hayashi Y, Jinnin M, Makino T, et al. Serum angiopoietin-like protein 3 concentrations in rheumatic diseases. Eur J Dermatol. 2012;22(4):500–504. doi:10.1684/ejd.2012.177422652544
   PubMed Web of Science ®Google Scholar
• Yang Y, Yang S, Jiao X, et al. ANGPTL3 mutations in unrelated Chinese Han patients with familial hypercholesterolemia. Curr Pharm Des. 2019. doi:10.2174/1381612825666190228000932
   Web of Science ®Google Scholar
• Jiang S, Qiu GH, Zhu N, Hu ZY, Liao DF, Qin L. ANGPTL3: a novel biomarker and promising therapeutic target. J Drug Target. 2019;1–9. doi:10.1080/1061186X.2019.1616296
   Web of Science ®Google Scholar
• Luo F, Guo Y, Fang Z, Li X. Concerns on the genetic or therapeutic antagonism of ANGPTL3. J Am Coll Cardiol. 2017;70(16):2099. doi:10.1016/j.jacc.2017.04.053
   Web of Science ®Google Scholar
• Tikka A, Metso J, Jauhiainen M. ANGPTL3 serum concentration and rare genetic variants in Finnish population. Scand J Clin Lab Invest. 2017;77(8):601–609. doi:10.1080/00365513.2017.137960828972399
   PubMed Web of Science ®Google Scholar
• Hanson RL, Leti F, Tsinajinnie D, et al. The Arg59Trp variant in ANGPTL8 (betatrophin) is associated with total and HDL-cholesterol in American Indians and Mexican Americans and differentially affects cleavage of ANGPTL3. Mol Genet Metab. 2016;118(2):128–137. doi:10.1016/j.ymgme.2016.04.00727117576
   PubMed Web of Science ®Google Scholar
• Sumegi K, Jaromi L, Magyari L, et al. Functional variants of lipid level modifier MLXIPL, GCKR, GALNT2, CILP2, ANGPTL3 and TRIB1 genes in healthy Roma and Hungarian populations. Pathol Oncol Res. 2015;21(3):743–749. doi:10.1007/s12253-014-9884-525573592
   PubMed Web of Science ®Google Scholar
• Járomi L, Csöngei V, Polgár N, et al. Triglyceride level-influencing functional variants of the ANGPTL3, CILP2, and TRIB1 loci in ischemic stroke. Neuromolecular Med. 2011;13(3):179–186. doi:10.1007/s12017-011-8149-721691831
   PubMed Web of Science ®Google Scholar
• Legry V, Bokor S, Cottel D, et al. Associations between common genetic polymorphisms in angiopoietin-like proteins 3 and 4 and lipid metabolism and adiposity in European adolescents and adults. J Clin Endocrinol Metab. 2009;94(12):5070–5077. doi:10.1210/jc.2009-076919890028
   PubMed Web of Science ®Google Scholar
• Li WJ, Yin RX, Cao XL, Chen WX, Huang F, Wu JZ. DOCK7-ANGPTL3 SNPs and their haplotypes with serum lipid levels and the risk of coronary artery disease and ischemic stroke. Lipids Health Dis. 2018;17(1):30. doi:10.1186/s12944-018-0677-929454388
   PubMed Web of Science ®Google Scholar